Table 2.
Differences in the questionnaires from baseline to week 12 and blood tests and CPET from baseline to week 6.
| N | TeleDiet group | Control group | p-value | ||
|---|---|---|---|---|---|
| Primary outcome | Mediterranean diet score | 50 | 2.0 [−1.0, 4.0]a | 0.0 [−3.0, 1.5] | 0.066 |
| Secondary outcomes | CoroPrevention Nutrition-Score | 50 | 3.0 [1.0, 3.5] | 0.0 [−3.0, 2.0] | 0.029 |
| GSES | 53 | 0.0 [−3.5, 1.0] | 0.0 [−1.0, 1.5] | 0.659 | |
| IMAB score | 53 | −0.2 (3.5) | −0.2 (3.1) | 0.968 | |
| HRQoL score | 53 | 7.4 (8.9) | 3.2 (7.0) | 0.063 | |
| Nutrition knowledge score | 53 | 1.9 (1.7) | 0.8 (2.1) | 0.048 | |
| LDL-cholesterol, mg/dL | 53 | −39 (53) | −44 (42) | 0.689 | |
| HDL-cholesterol, mg/dL | 53 | −2.2 (7.1) | −0.1 (7.7) | 0.303 | |
| HbA1c, % | 34 | 0.1 [0.0, 0.2] | −0.1 [−0.2, 0.2] | 0.457 | |
| Estimated GFR, mL/min | 52 | −6.0 [−8.5, 0.0] | −6.5 [−13.0, −0.5] | 0.819 | |
| Body mass index, kg/m2 | 56 | −0.3 [−1.0, 0.0] | 0.0 [−0.7, 0.3] | 0.679 | |
| Peak VO2, mL/min/kg | 44 | 1.3 [0.0, 3.2] | 1.9 [−0.3, 4.0] | 0.830 |
Values are mean (standard deviation) or median [interquartile range].
a
In the within-group analysis, there was a significant difference only in the TeleDiet group (p = 0.045).
CPET, cardiopulmonary exercise testing; GFR, glomerular filtration rate; GSES, General Self-Efficacy Scale; HbA1c, haemoglobin A1c; HDL, high-density lipoprotein; HRQoL, Health-related quality of life; IMAB, Identification of Medication Adherence Barriers; LDL, low-density lipoprotein; VO2, oxygen consumption.